Alimera Sciences To Present At Jefferies Healthcare Conference

        Alimera Sciences To Present At Jefferies Healthcare Conference

PR Newswire

ATLANTA, May 27, 2014

ATLANTA, May 27, 2014 /PRNewswire/ --Alimera Sciences, Inc. (Nasdaq: ALIM)
("Alimera"), a biopharmaceutical company that specializes in the research,
development and commercialization of prescription ophthalmic pharmaceuticals,
today announced that Dan Myers, president and chief executive officer, will
present at the Jefferies 2014 Healthcare Conference on Thursday, June 5, 2014
at 1:30 P.M. ET in New York, NY. 

The presentation will be webcast live and will be available for access on the
Investor Relations section of the corporate website at
http://www.alimerasciences.com. For those who are not available to listen to
the live broadcast, the webcast will be archived for 90 days.

About Alimera Sciences, Inc.

Alimera Sciences, Inc., headquartered in Alpharetta, Georgia, is a
biopharmaceutical company that specializes in the research, development and
commercialization of prescription ophthalmic pharmaceuticals. Alimera's
European operations are conducted from London by its wholly-owned subsidiary,
Alimera Sciences Limited.

ICR, LLC

for Alimera Sciences

John Mills

310-954-1105

John.Mills@icrinc.com

SOURCE Alimera Sciences, Inc.

Website: http://www.alimerasciences.com
 
Press spacebar to pause and continue. Press esc to stop.